XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.65

+2.6%

Jan 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jinping Shi who wrote (8957)	3/5/1999 11:58:00 PM
From: aknahow	Read Replies (3) of 17367

Appreciate your comment and the thought behind it. Worthwhile to remember for other trials including XOMA's :trauma" trial. But in the meningo trial the "problem" has been getting to a pre established mortality target for all enrolled in the trial. We believe 365 have ben enrolled and I think the target is higher than 30 but lower than 40 and it has not yet been reached. Given that all in the trial are at least 8 on the Glascow scale when enrolled, (some start at 12), it does not seem probable that your concept firs here. but again, I appreciate your suggestion and find it helpful.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next